EU And US Orphan Drug Regimes: Benefits And Limitations Of International Cooperation
Executive Summary
Daniel Kracov and Jackie Mulryne analyze the differences in data requirements for the authorization of orphan medicines in the EU and the US and the challenges they pose for global drug development.
You may also be interested in...
FDA Adds More MDRs, Deaths, To Philips Ventilator Tally
Less than a month after Philips released test results that it said showed the company’s much scrutinized sleep therapy devices were safe, the FDA has reported more complaints, including deaths, associated with the machines.
Novo Nordisk In Negotiations To Acquire Medical Device Maker Biocorp For About $165M (€154M)
After a nearly two-year collaboration, Novo Nordisk said it has begun talks to buy a controlling stake in French medical device company Biocorp.
Medtronic Creates Chief Technology And Innovation Officer Role
Ken Washington, the former general manager of consumer robotics, will help the company “accelerate innovation-driven growth.”